Walleye Trading LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$806,024
-13.5%
21,808
-10.6%
0.00%
-50.0%
Q3 2023$931,507
+343.5%
24,385
+343.4%
0.00%
Q1 2023$210,045
-95.9%
5,500
-93.9%
0.00%
-100.0%
Q4 2022$5,169,081
+899.8%
90,845
+593.5%
0.02%
+1400.0%
Q3 2022$517,000
-16.6%
13,100
-7.1%
0.00%0.0%
Q2 2022$620,000
-7.5%
14,099
-16.0%
0.00%0.0%
Q1 2022$670,000
-10.9%
16,785
-10.2%
0.00%
-66.7%
Q4 2021$752,000
-70.9%
18,700
-70.5%
0.00%
-66.7%
Q3 2021$2,580,000
+80.0%
63,400
+84.5%
0.01%
+50.0%
Q1 2021$1,433,000
-25.9%
34,371
-24.1%
0.01%
-33.3%
Q4 2020$1,935,000
-4.2%
45,300
-41.0%
0.01%
-18.2%
Q3 2020$2,019,000
-21.0%
76,800
-19.4%
0.01%
-31.2%
Q2 2020$2,555,000
+127.3%
95,300
+52.5%
0.02%
+77.8%
Q1 2020$1,124,000
+33.2%
62,500
+31.3%
0.01%
+50.0%
Q4 2019$844,000
+10.9%
47,600
-3.0%
0.01%0.0%
Q3 2019$761,000
+50.7%
49,053
+66.9%
0.01%
+20.0%
Q2 2019$505,00029,385
+122337.5%
0.01%
Q3 2018$0
-100.0%
24
-99.9%
0.00%
-100.0%
Q2 2018$290,000
-23.1%
17,200
-20.7%
0.00%
-50.0%
Q3 2017$377,000
+37600.0%
21,700
+21600.0%
0.00%
Q2 2017$1,000
-98.2%
100
-98.3%
0.00%
Q1 2016$55,000
+292.9%
5,800
+642.6%
0.00%
Q4 2015$14,000
+27.3%
781
+56.2%
0.00%
Q2 2015$11,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders